Maya was diagnosed with rheumatoid arthritis at age 17. Your generous donation can help her and other Canadians with arthritis live their lives to the fullest. Give a Gift of Hope.
Arthritis Research Canada’s signature event will take place on May 22, 2019 at The Roof, Hotel Vancouver. Please visit our save the date page for sponsorship opportunities and more.
We are recruiting individuals with and without inflammatory arthritis for a study that will explore the relationship between a person’s everyday activities and their health.
Your legacy gift to Arthritis Research Canada can make a future without pain and disability a reality for 5.6 million Canadians currently living with arthritis and for future generations.
Follow Us on Social Media
Did you know that 5.6 million Canadians have arthritis?
This #GivingTuesday, give a gift that will change lives for generations.
On November 27th, support arthritis research.
OUR LATEST RESEARCH
How much extra time do people with certain systemic autoimmune rheumatic diseases (SARDs) lose from paid and unpaid work, and what are the costs?
Scientific Study Title Excess Productivity Costs of Systemic Lupus Erythematosus, Systemic Sclerosis, and Sjogren’s Syndrome: A General Population-Based Study Principal Investigator Natalie McCormick, Ph.D. Research Trainee, Arthritis Research Canada Faculty of...read more
Aslam H. Anis. PhD, FCAHS. Professor, School of Population and Public Health, University of British Columbia
The goal of this research is to assess whether current price-cap regulations including the Pan-Canadian Generic Pricing Framework are efficient.read more
Biologic drugs for spondyloarthritis patients: do policies in different countries affect costs and health?
Principal Investigator: Stephanie Harvard, University of British Columbia School of Population and Public Health PhD student and Arthritis Research Canada Trainee supervised by Dr. Bruno Fautrel, Pierre and Marie Curie University, Paris, and Dr. Aslam Anis, University of British Columbia School of Population and Public Health
Using information from DESIR, researchers looked at which patients satisfied the criteria to receive biologic drugs in different countries: France, Canada, Germany, the United Kingdom and Hong Kong.read more
MEET THE TEAM
Scientific Director, MD, MPH, FRCPC, FCAHS
Board of Directors Chair